M LH1 (Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg)

Pill imprint M LH1 has been identified as Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg.

Hydrochlorothiazide/lisinopril is used in the treatment of high blood pressure; heart failure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/lisinopril 12.5 mg / 10 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M LH1

Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg M LH1 Front
Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg M LH1 Back
Hydrochlorothiazide and lisinopril 12.5 mg / 10 mg M LH1
Hydrochlorothiazide and lisinopril
Imprint:
M
LH1
Strength:
12.5 mg / 10 mg
Color:
White
Size:
9.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Antihypertensive combinations
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-1012
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
calcium phosphate dihydrate dibasic
magnesium stearate
mannitol
microcrystalline cellulose
povidone
corn starch
sodium lauryl sulfate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0697 UDL Laboratories Inc

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)